Back to top
more

Inogen (INGN)

(Delayed Data from NSDQ)

$12.51 USD

12.51
256,355

+0.29 (2.37%)

Updated Aug 23, 2024 04:00 PM ET

After-Market: $12.49 -0.02 (-0.16%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value A Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 32% (81 out of 251)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

Inogen Rides on Solid Product Portfolio Amid Forex Woes

Inogen's (INGN) expanding product portfolio is a key catalyst. Foreign exchange headwinds continue to hurt the company's growth trajectory.

    Inogen Claims Top Position in Deloitte List on Solid Growth

    Inogen's (INGN) unique direct-to-customer business model has lent it a leading position in the United States.

      Inogen (INGN) Beats Earnings and Revenue Estimates in Q3

      Inogen's (INGN) stellar third-quarter numbers benefit from direct-to-consumer sales and lower cost of goods sold per unit.

        McKesson (MCK) to Acquire RxCrossroads for $735 Million

        McKesson's (MCK) acquisition of RxCrossroads will boost its Specialty Health business.

          Inogen (INGN) Hits a 52-Week High: What's Driving the Stock?

          Inogen (INGN) develops, manufactures and markets POCs. The company's direct-to-customer business model lent it a leading position in the oxygen therapy space.

            Inogen (INGN) Down 2.4% Since Earnings Report: Can It Rebound?

            Inogen (INGN) reported earnings about a month ago. What's next for the stock? We take a look at earnings estimates for some clues.

              Zacks.com featured highlights: SP Plus, Inogen, Graco, Sterling Construction and FireEye

              Zacks.com featured highlights: SP Plus, Inogen, Graco, Sterling Construction and FireEye

                5 Stocks to Beat the Market This Reporting Cycle

                Inside the stocks that are likely to beat earnings estimates in their upcoming releases.

                  Inogen (INGN) Beats Earnings and Revenue Estimates in Q2

                  Inogen (INGN) delivers better-than-expected results in Q2 with significant contributions from the Business-to-Business segment. Moreover, raised guidance buoys optimism.

                    Myriad Genetics to Grow with Study Successes, New Alliances

                    On Jul 6, we issued an updated research report on Myriad Genetics, Inc. (MYGN).

                      Medtronic (MDT) Launches Resolute Onyx DES Device in Japan

                      Medtronic plc (MDT), a leading global player in medical technology, services and solutions, is set to make another encouraging move with respect to its highest revenue grossing Cardiovascular segment.

                        Thermo Fisher at a 52-Week High: What's Driving the Stock?

                        Share price of Thermo Fisher Scientific Inc. (TMO), headquartered in Waltham, MA, scaled a new 52-week high of $177.99 on Jul 7, eventually closing a shade lower at $177.49.

                          Investors Look for Gains as Abbott Labs Set to Acquire Alere

                          On majority of Alere shareholders' recent approval in favor of the merger with Abbott (ABT), the deal is now expected to close by the end of third-quarter 2017.

                            Zacks Industry Outlook Highlights: Varian Medical Systems, Inogen, Edwards Lifesciences, Orthofix International and INSYS Therapeutics

                            Zacks Industry Outlook Highlights: Varian Medical Systems, Inogen, Edwards Lifesciences, Orthofix International and INSYS Therapeutics

                              ResMed Sees Potential in SDB Market, Eyes Global Growth

                              On Jul 6, we issued an updated research report on San Diego, CA-based ResMed, Inc. (RMD).

                                Baxter and TAU Ink New Licensing Agreements through Ramot

                                Baxter International (BAX) has recently teamed up with Tel Aviv University, Israel's largest research and teaching university (TAU), on two new licensing agreements through Ramot.

                                  Mazor Expects Higher Q2 Revenues, Wins Mazor X Orders

                                  Mazor Robotics Ltd. (MZOR), recently announced that it expects to report second-quarter 2017 revenue of approximately $15.4 million compared with $8.3 million from the year-ago quarter.

                                    Phibro Animal Health & Zydus Cadila Plan to Expand in India

                                    Phibro Animal Health Corporation (PAHC) recently announced plans to enter into a long-term agreement with global pharmaceutical company Zydus Cadila to expand in the rapidly growing poultry market in India.

                                      Edwards Lifesciences' INSPIRIS RESILIA Valve Wins FDA Nod

                                      Edwards Lifesciences Corporation (EW) recently announced the receipt of FDA approval for its INSPIRIS RESILIA aortic valve.

                                        Will Walgreens Gain from Revised Rite Aid Agreement?

                                        The new agreement would enable Walgreens Boots Alliance (WBA) to buy nearly half of the Rite Aid business at a deal value, almost one-third of the original price.

                                          Exactech Boosts Knee System Portfolio, Launches New App

                                          Exactech, Inc.(EXAC) took a step towards it's goal of providing an all-inclusive range of knee replacement systems with the launch of ExactechGPS TKA PLUS.

                                            Here's Why You Should Add Abbott Laboratories Right Now

                                            Illinois-based global medical device company Abbott Laboratories (ABT) has been gaining investor confidence on consistent positive results

                                              Envision Healthcare Rallies on Infinity Healthcare Buyout

                                              Envision Healthcare Corporation (EVHC) recently announced that Envision Physician Services has acquired Infinity Healthcare, a multi-specialty physician group practice.

                                                Nevro (NVRO) Surges: Stock Moves 11.4% Higher

                                                Nevro (NVRO) was a big mover last session, as the company saw its shares rise over 11% on the day.

                                                  Exactech (EXAC) Launches Application for Knee Replacement

                                                  Gainesville, FL-based Exactech Inc. (EXAC) recently announced the launch of a new software application christened ExactechGPS TKA PLUS.